SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 162 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $517,000 | +88.7% | 36,715 | 0.0% | 0.01% | +75.0% |
| Q2 2017 | $274,000 | +14.2% | 36,715 | -0.5% | 0.00% | 0.0% |
| Q1 2017 | $240,000 | +46.3% | 36,915 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $164,000 | -4.7% | 36,915 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $172,000 | -29.2% | 36,915 | 0.0% | 0.00% | -40.0% |
| Q2 2016 | $243,000 | +3.8% | 36,915 | +0.5% | 0.01% | 0.0% |
| Q1 2016 | $234,000 | +5.9% | 36,719 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $221,000 | +3.3% | 36,719 | +2.8% | 0.01% | -16.7% |
| Q3 2015 | $214,000 | -12.3% | 35,719 | 0.0% | 0.01% | -14.3% |
| Q2 2015 | $244,000 | +12.4% | 35,719 | 0.0% | 0.01% | +16.7% |
| Q1 2015 | $217,000 | -12.5% | 35,719 | 0.0% | 0.01% | -25.0% |
| Q4 2014 | $248,000 | -14.8% | 35,719 | 0.0% | 0.01% | -11.1% |
| Q3 2014 | $291,000 | +0.3% | 35,719 | 0.0% | 0.01% | -10.0% |
| Q2 2014 | $290,000 | – | 35,719 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
| ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
| NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
| Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
| Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
| Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
| J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
| J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
| Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |